Literature DB >> 26723917

The stabilization of hypoxia inducible factor modulates differentiation status and inhibits the proliferation of mouse embryonic stem cells.

Lucia Binó1, Jan Kučera2, Kateřina Štefková2, Lenka Švihálková Šindlerová3, Martina Lánová2, Jana Kudová4, Lukáš Kubala5, Jiří Pacherník6.   

Abstract

Hypoxic conditions are suggested to affect the differentiation status of stem cells (SC), including embryonic stem cells (ESC). Hypoxia inducible factor (HIF) is one of the main intracellular molecules responsible for the cellular response to hypoxia. Hypoxia stabilizes HIF by inhibiting the activity of HIF prolyl-hydroxylases (PHD), which are responsible for targeting HIF-alpha subunits for proteosomal degradation. To address the impact of HIF stabilization on the maintenance of the stemness signature of mouse ESC (mESC), we tested the influence of the inhibition of PHDs and hypoxia (1% O2 and 5% O2) on spontaneous ESC differentiation triggered by leukemia inhibitory factor withdrawal for 24 and 48 h. The widely used panhydroxylase inhibitor dimethyloxaloylglycine (DMOG) and PHD inhibitor JNJ-42041935 (JNJ) with suggested higher specificity towards PHDs were employed. Both inhibitors and both levels of hypoxia significantly increased HIF-1alpha and HIF-2alpha protein levels and HIF transcriptional activity in spontaneously differentiating mESC. This was accompanied by significant downregulation of cell proliferation manifested by the complete inhibition of DNA synthesis and partial arrest in the S phase after 48 h. Further, HIF stabilization enhanced downregulation of the expressions of some pluripotency markers (OCT-4, NANOG, ZFP-42, TNAP) in spontaneously differentiating mESC. However, at the same time, there was also a significant decrease in the expression of some genes selected as markers of cell differentiation (e.g. SOX1, BRACH T, ELF5). In conclusion, the short term stabilization of HIF mediated by the PHD inhibitors JNJ and DMOG and hypoxia did not prevent the spontaneous loss of pluripotency markers in mESC. However, it significantly downregulated the proliferation of these cells.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  DMOG; Embryonic stem cells; HIF-1; Hypoxia; JNJ-42041935; Prolyl hydroxylase

Mesh:

Substances:

Year:  2015        PMID: 26723917     DOI: 10.1016/j.cbi.2015.12.007

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  5 in total

Review 1.  The role of α-ketoglutarate-dependent proteins in pluripotency acquisition and maintenance.

Authors:  Khoa A Tran; Caleb M Dillingham; Rupa Sridharan
Journal:  J Biol Chem       Date:  2018-09-04       Impact factor: 5.157

2.  Hypoxia Downregulates MAPK/ERK but Not STAT3 Signaling in ROS-Dependent and HIF-1-Independent Manners in Mouse Embryonic Stem Cells.

Authors:  Jan Kučera; Julie Netušilová; Stanislava Sladeček; Martina Lánová; Ondřej Vašíček; Kateřina Štefková; Jarmila Navrátilová; Lukáš Kubala; Jiří Pacherník
Journal:  Oxid Med Cell Longev       Date:  2017-07-27       Impact factor: 6.543

3.  Hypoxia favors myosin heavy chain beta gene expression in an Hif-1alpha-dependent manner.

Authors:  Lucia Binó; Jiřina Procházková; Katarzyna Anna Radaszkiewicz; Jan Kučera; Jana Kudová; Jiří Pacherník; Lukáš Kubala
Journal:  Oncotarget       Date:  2017-07-05

4.  Intraperitoneal injection of Desferal® alleviated the age-related bone loss and senescence of bone marrow stromal cells in rats.

Authors:  Lingxian Yi; Yue Ju; Ying He; Xiushan Yin; Ye Xu; Tujun Weng
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

5.  Chemical Activation of the Hypoxia-Inducible Factor Reversibly Reduces Tendon Stem Cell Proliferation, Inhibits Their Differentiation, and Maintains Cell Undifferentiation.

Authors:  Alessandra Menon; Pasquale Creo; Marco Piccoli; Sonia Bergante; Erika Conforti; Giuseppe Banfi; Pietro Randelli; Luigi Anastasia
Journal:  Stem Cells Int       Date:  2018-03-11       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.